Catalyst Wire Dossier Catalyst Wire Dossier

ERMEZA

LEVOTHYROXINE SODIUM · Viatris Specialty LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ERMEZA, covering 2022-04-29 to 2022-04-29. Get the full timeline:

Most recent: FDA Approved: ERMEZA — Original Application (Viatris Specialty LLC)

See pricing